HEALTHJul 31 · 17:02 UTCSTAT NEWSEd Silverman

STAT+: Trump administration revises rebate pilot for 340B drug discount program, angering hospitals

The Trump administration revised a pilot for the 340B Drug Pricing Program, allowing pharmaceutical companies to offer rebates instead of upfront discounts. The change, effective Jan. 1, 2027, targets drugs and companies involved in Medicare Drug Price Negotiation Program rounds, angering hospitals and clinics.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

Trump administrationorganizationTom EngelspersonHealth Resources and Services Administrationorganization340B Drug Pricing ProgramtopicMedicare Drug Price Negotiation Programtopic

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHJul 2 · 14:22 UTC
A proposed Medicare reimbursement change could reshape hospital drug pricing
HEALTHJun 12 · 21:45 UTC
STAT+: Trump administration revisits policy to close Medicare drug price negotiation loophole
HEALTHJul 2 · 12:45 UTC
Trump administration proposes a rule it says could save Medicare patients $1.1 billion on drugs
HEALTHJul 2 · 16:39 UTC
Trump administration proposes a rule it says could save Medicare patients $1.1 billion on drugs
HEALTHJul 14 · 19:57 UTC
STAT+: Sales from controversial U.S. drug discount program rose to $100 billion last year
HEALTHJul 2 · 12:45 UTC
Trump administration proposes a rule it says could save Medicare patients $1.1 billion on drugs